Table 1.

Frequency of treatment decisions and values of PAS-II components in each disease category.

CategoryTreatment Decision, n (%)Change Because of Side EffectsHAQ-II, mean (SD)Pain, mean (SD)Patient Global, mean (SD)
No ChangeIncreased IntensityDecreased Intensity
Rheumatoid arthritis118 (40.0)140 (47.5)28 (9.5)9 (3.1)0.95 (0.65)4.11 (2.78)3.78 (2.58)
Other inflammatory arthritis116 (42.6)131 (48.2)15 (5.5)10 (3.7)0.77 (0.62)4.06 (2.78)3.86 (2.63)
Noninflammatory disorder37 (49.3)36 (48.0)2 (2.7)0 (0.0)1.06 (0.65)5.18 (2.58)4.75 (2.51)
Autoimmune connective tissue disease55 (50.5)40 (36.7)10 (9.2)4 (3.7)0.70 (0.59)3.56 (2.80)3.73 (2.65)
Other60 (45.5)40 (30.3)30 (22.7)2 (1.5)0.84 (0.69)3.93 (3.03)3.54 (2.63)
  • PAS: Patient Activity Scale; HAQ: Health Assessment Questionnaire.